DGAP-News: Westhouse Medical Services Plc announces appointment of new Board member
(firmenpresse) - DGAP-News: Westhouse Medical Services plc / Key word(s): Change of
Personnel/Corporate Action
Westhouse Medical Services Plc announces appointment of new Board
member
21.03.2012 / 07:00
---------------------------------------------------------------------
Westhouse Medical Services Plc announces appointment of new
Board member
Director appointment part of company's international corporate expansion
LONDON, UK, 21st March 2012 - Healthcare specialist Westhouse Medical
Services Plc ('Ticker Symbol 5WM') today announces, with immediate effect,
the appointment of Mr. Jonathan Rothman as a non-executive director.
Rothman has over thirty years experience in the financial sector, most
recently as a partner within the 'Met Group' where he was responsible for
creating and structuring new companies within the business' portfolio, in
Switzerland and the UK.
Previously Rothman spent fourteen years working with investment and
portfolio consultants, advising and managing a number of fixed income
funds, following a period as head of Swiss Franc equity derivatives at
Cantor Fitzgerald.
Rothman started his career as a trader on the floor of the London Stock
Exchange before moving into Eurobond trading with Swiss Bank Corporation
International and Nikko Securities.
Jack Kaye, founder and CEO of Westhouse Medical Services commented: 'We are
pleased to welcome Jonathan on to the Westhouse Medical Services Board. He
brings a wealth of business and financial sector experience to the company,
which will be invaluable to us as we continue our acquisitive growth
internationally within the healthcare sector.'
Westhouse is currently developing a number of medical devices, including
BreastCheck - a new low-cost, non-invasive breast cancer screening product
which can act as a precursor to mammogram scanning. BreastCheck is due for
launch in summer 2012.
Westhouse recently entered into negotiations for the acquisition of a
majority stake in US listed Sunridge International. Sunridge's subsidiary,
Ophthalmic International Inc., has developed a glaucoma procedure called
PNT, which could revolutionise the way glaucoma is treated globally.
WESTHOUSE MEDICAL SERVICES PLC
SYMBOL: 5WM
WKN: A1JKH7
ISIN: GB00B6YWDK49
SEDOL: B6YWDK4
~ends~
For press information, contact:
Jo Lee / Sian Edwards/ George Baggaley
Chameleon PR
Email: westhouse(at)chameleonpr.com
Ph: +44 (0) 207 680 5500
End of Corporate News
---------------------------------------------------------------------
21.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
161473 21.03.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
Datum: 21.03.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 126839
Anzahl Zeichen: 11960
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 201 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Westhouse Medical Services Plc announces appointment of new Board member"
steht unter der journalistisch-redaktionellen Verantwortung von
Westhouse Medical Services plc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).